BAYN DE000BAY0017

Report

Delayed Xetra - 05/26 11:38:55 am EDT
65.90	EUR		+3.32%

05:13a	BAYER AG : Deutsche Bank keeps its Buy rating	MD
02:18a	BAYER AG : Bernstein reaffirms its Buy rating	MD
05/25	Bayer CropScience's Net Profit Soars in Fiscal Q4	MT

Summary

Quotes 5-day view Delayed Quote.

Delayed Xetra

05/20/2022	05/23/2022	05/24/2022	05/25/2022	05/26/2022	Date
63.74(c)	64.47(c)	63.29(c)	63.78(c)	65.9(c)	Last
2 625 237	2 202 703	2 582 622	1 738 849	3 149 253	Volume
+0.54%	+1.15%	-1.83%	+0.77%	+3.32%	Change

More quotes

Estimated financial data (e)

Sales 2022	47 605 M 51 067 M 51 067 M
Net income 2022	4 996 M 5 360 M 5 360 M
Net Debt 2022	33 100 M 35 507 M 35 507 M
P/E ratio 2022	13,0x
Yield 2022	3,35%

Sales 2023	48 921 M 52 479 M 52 479 M
Net income 2023	5 667 M 6 079 M 6 079 M
Net Debt 2023	30 650 M 32 879 M 32 879 M
P/E ratio 2023	11,5x
Yield 2023	3,70%

Capitalization	64 742 M 69 450 M 69 450 M
EV / Sales 2022	2,06x
EV / Sales 2023	1,95x
Nbr of Employees	100 753
Free-Float	100,0%

More Financials

Company

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (45.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (41.6%) : intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc. ; - OTC...

Sector

Pharmaceuticals

Calendar

08/04

Earnings Release

More about the company

Ratings of Bayer AG

Trading Rating :

Investor Rating :

ESG Refinitiv :

B-

More Ratings

All news about BAYER AG

05:13a	BAYER AG : Deutsche Bank keeps its Buy rating	MD
02:18a	BAYER AG : Bernstein reaffirms its Buy rating	MD
05/25	Bayer CropScience's Net Profit Soars in Fiscal Q4	MT
05/24	Bayer Commits To UN's Zero Hunger Private Sector Pledge	MT
05/23	Bayer's Kerendia Found to Reduce Hospitalization for Heart Failure in Exploratory Post ..	MT
05/23	BAYER : New data support renal and cardiovascular benefits of Kerendia™ (finerenone)..	PU
05/23	Bayer's Xarelto Shows Long-Term Effect in Heart Disease Patients	MT
05/23	BAYER : Two large Xarelto™ studies support effectiveness of dual pathway inhibition ..	PU
05/20	Fitch Maintains Bayer's Rating, Stable Outlook on Strong Operating Performance	MT
05/19	Atara Biotherapeutics, Bayer Collaboration on CAR T-cell Therapies to be Terminated in ..	MT
05/19	Atara Biotherapeutics, Inc. Receives Written Notice of Termination from Bayer AG of the..	CI
05/19	BAYER AG : Buy rating from UBS	MD
05/19	Bayer Secures Authorization for Chronic Heart Failure Therapy in China	MT
05/17	Bayer's New Therapeutic Option to Reduce Risk of Cardiovascular Deaths and Repeated Hos..	CI
05/16	China's LongPing to launch Brazil sorghum seed next year	RE

More news

News in other languages on BAYER AG

12:24p	MÄRKTE EUROPA/Käufe zu Christi Himmelfahrt - Einzelhandelsaktien sehr fest
11:57a	XETRA-SCHLUSS/DAX fest - Aufwärtsbewegung gewinnt an Breite
10:26a	MÄRKTE EUROPA/Aufwärts - Wall Street sorgt für neuen Anschub
08:27a	AKTIEN FRANKFURT : Dax baut Gewinne etwas aus
06:45a	MÄRKTE EUROPA/Aktien an Christi Himmelfahrt mit leichten Gewinnen

More news

Analyst Recommendations on BAYER AG

05:13a	BAYER AG : Deutsche Bank keeps its Buy rating	MD
02:18a	BAYER AG : Bernstein reaffirms its Buy rating	MD
05/19	BAYER AG : Buy rating from UBS	MD

More recommendations

Provided by Scoopnest.com

Analysis

GE unit boosts medical dye output as China COVID lockdown cuts supplies